Obagi Medical Products, Inc. - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Obagi Medical Products, Inc.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Obagi Medical Products, Inc.. The Group's principal activity is to develop and market prescription-based, topical skin health systems in the aesthetic and therapeutic skin health markets. It helps physicians to treat a range of skin conditions, including pre-mature aging, photo-damage, hyper pigmentation, acne and soft tissue deficits, such as fine lines and wrinkles. Its product lines are prescription-based skin health systems that improve the efficacy of established prescription and over-the-counter, therapeutic agents by enhancing the penetration of these agents across the skin barrier using proprietary technologies. It also licenses certain non-prescription product concepts under the Obagi trademark to a large Japanese based Pharmaceutical company. The Group introduced ELASTIdermTM product line, ELASTIdermTM Eye Cream, a for treatment of skin laxity around the eye.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report